Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan M Baird

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Ejhaem|January 27, 2025
A novel TERT variant associated with a telomere biology disorder and challenges in variant classificationVahid Pazhakh, Lucy C Fox, Nicole Den Elzen, et al.
DNA Repair|December 10, 2024
Corrigendum to "BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination" [DNA Repair 115 (2022) 103331]Christopher Parker, Adam C Chambers, Dustin J Flanagan, et al.
DNA Repair|April 25, 2022
BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombinationChristopher Parker, Adam C Chambers, Dustin J Flanagan, et al.
British Journal of Haematology|May 10, 2017
Telomere length is an independent prognostic marker in MDS but not in de novo AMLJenna Williams, Nicole H Heppel, Bethan Britt-Compton, et al.
Frontiers in Medicine|May 11, 2026
TeloNet is born: why all specialities need to be aware of telomere biology disordersHilary J Longhurst, Jane K Paxton, Hemanth Tummala, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2018
CCR8 Expression Defines Tissue-Resident Memory T Cells in Human SkinMichelle L McCully, Kristin Ladell, Robert Andrews, et al.
NEJM Evidence|February 25, 2025
Clinical Use of ZSCAN4 for Telomere Elongation in Hematopoietic Stem CellsKasiani C Myers, Stella M Davies, Carolyn Lutzko, et al.
Cell Reports|December 16, 2016
Human Stem Cell-like Memory T Cells Are Maintained in a State of Dynamic FluxRaya Ahmed, Laureline Roger, Pedro Costa Del Amo, et al.
British Journal of Haematology|July 4, 2014
Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage diseaseThet Thet Lin, Kevin Norris, Nicole H Heppel, et al.
Neuro-Oncology|January 25, 2023
Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volumeElisa Aquilanti, Lauren Kageler, Jacqueline Watson, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Ejhaem|January 27, 2025
A novel TERT variant associated with a telomere biology disorder and challenges in variant classificationVahid Pazhakh, Lucy C Fox, Nicole Den Elzen, et al.
DNA Repair|December 10, 2024
Corrigendum to "BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination" [DNA Repair 115 (2022) 103331]Christopher Parker, Adam C Chambers, Dustin J Flanagan, et al.
DNA Repair|April 25, 2022
BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombinationChristopher Parker, Adam C Chambers, Dustin J Flanagan, et al.
British Journal of Haematology|May 10, 2017
Telomere length is an independent prognostic marker in MDS but not in de novo AMLJenna Williams, Nicole H Heppel, Bethan Britt-Compton, et al.
Frontiers in Medicine|May 11, 2026
TeloNet is born: why all specialities need to be aware of telomere biology disordersHilary J Longhurst, Jane K Paxton, Hemanth Tummala, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2018
CCR8 Expression Defines Tissue-Resident Memory T Cells in Human SkinMichelle L McCully, Kristin Ladell, Robert Andrews, et al.
NEJM Evidence|February 25, 2025
Clinical Use of ZSCAN4 for Telomere Elongation in Hematopoietic Stem CellsKasiani C Myers, Stella M Davies, Carolyn Lutzko, et al.
Cell Reports|December 16, 2016
Human Stem Cell-like Memory T Cells Are Maintained in a State of Dynamic FluxRaya Ahmed, Laureline Roger, Pedro Costa Del Amo, et al.
British Journal of Haematology|July 4, 2014
Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage diseaseThet Thet Lin, Kevin Norris, Nicole H Heppel, et al.
Neuro-Oncology|January 25, 2023
Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volumeElisa Aquilanti, Lauren Kageler, Jacqueline Watson, et al.
Pageof 9